DNLI
Denali Therapeutics Inc

1,667
Loading...
Loading...
Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau. The company was founded by Ryan J. Watts, Marc Tessier-Lavigne, and Alexander Schuth on October 14, 2013 and is headquartered in San Francisco, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
422

Frequently Asked Questions

What is Market Cap of Denali Therapeutics Inc?
What is the 52-week high for Denali Therapeutics Inc?
What is the 52-week low for Denali Therapeutics Inc?
What is Denali Therapeutics Inc stock price today?
What was Denali Therapeutics Inc stock price yesterday?
What is the PE ratio of Denali Therapeutics Inc?
What is the Price-to-Book ratio of Denali Therapeutics Inc?
What is the 50-day moving average of Denali Therapeutics Inc?
How many employess does Denali Therapeutics Inc has?

Latest DNLI News

View

Advertisement. Remove ads.

Advertisement. Remove ads.